Antithrombin III inhibits T and B lymphocyte activation in vitro and improves parameters of inflammation in a rat model of acute lung allograft rejection

Transplant Proc. 1999 Feb-Mar;31(1-2):847-8. doi: 10.1016/s0041-1345(98)01800-4.

Authors

X J Zuo¹, Y Okada, E Nicolaidou, T Toyoda, A Marchevsky, J M Matloff, S C Jordan

Affiliation

¹ Steven Spielberg Pediatric Research Center, Department of Cardiothoracic Surgery and Pathology, Cedars-Sinai Medical Center, UCLA School of Medicine, USA.

PMID: 10083370
DOI: 10.1016/s0041-1345(98)01800-4

No abstract available

MeSH terms

Acute Disease
Animals
Antibody Formation
Antithrombin III / pharmacology*
Antithrombin III / physiology
B-Lymphocytes / drug effects
B-Lymphocytes / immunology*
Cells, Cultured
Disease Models, Animal
Graft Rejection / immunology*
Humans
Inflammation / immunology
Lung Transplantation / immunology*
Lymphocyte Activation / drug effects*
Lymphocyte Culture Test, Mixed
Rats
Rats, Inbred BN
Rats, Inbred Lew
Spleen / immunology
T-Lymphocytes / drug effects
T-Lymphocytes / immunology*
Transplantation, Homologous

Substances

Antithrombin III